Retiring Soon? How to Beat Your Biggest Money Fears
Is 'Good Debt' Ruining Your Chance of Retiring?
How to Have a Successful Money Talk With Your Significant Other
After Market: Bah, Humbug! Still No Sign of the Usual Christmas Rally
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.